NCT00511524
- Conditions
- Agnosia, Inflammation, Nervous System Diseases, +8 more
- Locations
-
- GSK Investigational Site Uppsala, Sweden
Clinical trial condition
Explore clinical trials studying Neurobehavioral Manifestations. Study availability and eligibility vary by location and protocol.
NCT00511524
NCT02222246
NCT02706522
Not specified
NCT02064894
NCT00571688
NCT00613821
NCT02889068
NCT00628589
NCT00721955
NCT00368940